Evaluation of biomarker potential of Cystatin B for detection of ovarian cancer

Evaluation of biomarker potential of Cystatin B for detection of ovarian cancer - Evaluation of biomarker potential of Cystatin B for detection of ovarian cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025292

Enrollment

120

Registered

2016-12-15

Start date

2016-12-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer, Endometriosis, Uterine fibroid

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Ovarian cancer patients newly diagnosed (all ages) 2. Endometriosis patients newly diagnosed 3. Uterine fibroid patients newly diagnosed

Exclusion criteria

Exclusion criteria: 1. Previous history of any cancers 2. Multiple malignancies 3. Patients previously treated 4. Individuals who did not accept informed consent 5. Inappropriateness by doctor's judgement

Design outcomes

Primary

Measure	Time frame
Comparison of the area under the curve (AUC) of Reciever Operating Characteristic Curves (ROC curves) between serum CSTB and CA125	—

Countries

Japan

Contacts

Public ContactIshino Kousuke

Nippon Medical School Department of Integrated Diagnostic Pathology

kishino@nms.ac.jp03-3822-2131

Outcome results